Report Overview
The global Postbiotics Food Supplements Market was valued at US$ 10.8 million in 2023 and is projected to reach US$ 27.3 million by 2031, growing at a CAGR of 10.5% during 2025-2032. The postbiotics food supplements market grows due to the stability and immunomodulation benefits of non-viable microbial metabolites over probiotics. Asia-Pacific leads with a strong preventive health culture, while North America accelerates with rising consumer awareness. Demand for postbiotics in capsules, powders, and beverages rises for gut and immune health applications.
Postbiotics food supplements excel in heat-stable formats, making them ideal for dairy, beverages, and functional foods. The post-COVID focus on immunity boosts demand, despite supply chain challenges from global disruptions. Innovations in short-chain fatty acids and enzymes enhance efficacy. Regulatory advancements are supporting broader market adoption globally.
Get a Sample PDF Brochure of the Report Download Sample
Key Highlights
Market Growth: The postbiotics food supplements market grows from US$ 10.8 million in 2023 to US$ 27.3 million by 2031 at a CAGR of 10.5%.
Asia-Pacific Dominance: Leads with demand for maternal and gut health solutions.
Digestive Health Focus: Dominates applications for microbiome balance and relief.
Stability Advantage: Enables versatile use without live microbial requirements.
Key Types: Short-chain fatty acids and enzymes drive therapeutic efficacy.
Major Players: Kerry and Tetra Pak innovate in delivery and formulation systems.
Market Dynamics
Drivers: Scientific Validation and Food Integration
Scientific studies from 2022 validate postbiotics’ anti-inflammatory effects via IL-12, boosting demand in the postbiotics food supplements market. Their heat stability suits UHT processing in beverages and dairy, expanding applications. Kerry’s 2024 Plenibiotic launch offers low-dose digestive benefits for humans and pets. Consumer focus on immunity post-COVID drives adoption across diverse food formats globally.
Restraints: Regulatory Gaps and Supply Challenges
The absence of specific EFSA and FDA regulations for postbiotics complicates health claim approvals, hindering market growth. War-related disruptions increase raw material costs, impacting scalability. Limited consumer awareness in some regions slows adoption rates. Compliance costs pose challenges for smaller manufacturers, limiting their market entry.
Segmentation Analysis
By Application
Digestive Health leads the postbiotics food supplements market, addressing constipation and bloating with proven efficacy. Immune Support and Skin Health applications follow, driven by consumer interest in holistic wellness. Maternal health applications gain traction, particularly in Asia-Pacific.
By Type
Short-chain fatty acids and Lipopolysaccharides dominate for their antimicrobial and immune-modulating properties. Enzymes are emerging for metabolic support in functional foods.
By Form
Capsules & Tablets lead for convenient dosing, while Powders grow in beverage and food applications due to their versatility.
By Distribution Channel
Online Retailers and Pharmacies expand access, with supermarkets emerging as key channels for mass-market products.
Geographical Analysis
Asia-Pacific: Largest Market Share
Asia-Pacific dominates the postbiotics food supplements market with high birth rates and a cultural preference for natural remedies. Research validates postbiotics for infant and maternal health, driving adoption in Japan and China. Preventive care trends and rising disposable incomes fuel market growth.
Other Regions
North America grows fastest due to increasing consumer awareness and health campaigns. Europe faces challenges from rising energy costs but advances through research investments. South America and the Middle East & Africa show gradual uptake with improving distribution networks.
Major Companies
Key players include:
ADM
Cargill Incorporated
ABbiotek Health
Tetra Pak International S.A.
DSM
AB-BIOTICS, SA
Sabinsa
Postbiotica Srl
Lesaffre
Lactobio A/S
Recent Developments
February 2024: Kerry launched Plenibiotic, a rice-derived postbiotic for human and pet gut health.
October 2023: Tetra Pak and AB Biotek debuted powder postbiotics for UHT-processed foods.
2023: Postbiotics were integrated into kefir and yogurt for enhanced nutrient profiles.
2022: Studies confirmed the efficacy of heat-killed Lactobacillus in neonatal health applications.
Get Customisation in the Report as per Your Requirements: Customize Report
Report Scope
Metrics
CAGR: 10.5%
Market Size Available: 2022-2032
Forecast Period: 2025-2032
Revenue Units: US$ Million
Segmentation
Type: Short-chain fatty acids, Enzymes, Lipopolysaccharides, Others
Application: Digestive Health, Immune Support, Skin Health, Maternal Health, Others
Form: Capsules & Tablets, Powder, Liquids, Others
Distribution Channel: Online Retailers, Pharmacies, Supermarkets, Others
About DataM Intelligence
DataM Intelligence 4Market Research is a leading market intelligence platform offering syndicated and customized reports across industries like biotechnology, healthcare, and pharmaceuticals. With comprehensive insights, statistical forecasts, and a strategy-centric approach, DataM Intelligence supports businesses in bringing innovations to market. The platform empowers companies with actionable data to navigate competitive landscapes effectively. By delivering precise market intelligence, it enables firms to achieve sustainable growth and maintain leadership in dynamic markets.
Comments
Post a Comment